Navigation Links
Large Scale Multiple Sclerosis Vaccine Trial to Be Initiated By PharmaFrontiers

It might not be long before a vaccine for multiple sclerosis is made available. Following the promising results of a multiple sclerosis vaccine trial// in a small group of patients, PharmaFrontiers, a leading pharmaceutical company is all set to test it’s vaccine on a large scale.

Multiple sclerosis is a disease in which the myelin sheath, surrounding the nerve fibers in the spinal cord and brain is destroyed. Owing to destruction of this protective sheath, the transmission of nerve impulses to the brain is affected. Approximately 2.5 million people are afflicted by the disease, every year.

The vaccine contains inactivated myelin-specific T cells, normally found in the immune system. These cells are produced in the laboratory by radiation treatment of the extracted, multiplied and processed T-lymphocytes. The cells are then re-injected back into the patient, activating the immune system. It has been known from previous trials that re-injection of the modified T-cells eliminates the damaged nerve cells.

In some cases, the immune system also attacks the normal cells, leading to complications. In view of the above drawback, the researchers have been urged to be cautious by MS experts, who point out to other vaccine trials that have been ineffective.

The new vaccine trial would compare the progress of the disease among 100 people who have already received the vaccination with the control group (not vaccinated). It is believed that if the results of the earlier study were replicated, it might even be possible to attenuate or stop the disease progress.


'"/>




Page: 1

Related medicine news :

1. The Link Between Larger Birth Weight And Cancer Risk
2. Worlds Largest Cord Blood Bank to be started in India
3. India Has The Oldest And Largest Collection Of Preserved Mosquitoes – Mosquito Museu
4. Fear Of Dengue Epidemic Looms Large: Fever Kills Five in Pakistan
5. Visualization Found To Be Largely Dependent On The Brain
6. Large Scale Study On H5N1 Conducted
7. Pre-eclampsia Pronounced With Intake of Vitamins in Large Doses
8. Large Ambulances To Handle Obese patients In Vegas
9. Heart Related Problems-The Largest Killers In Andhra Pradesh
10. Large scale culling of poultry effected at Cote dIvoire following bird flu outbreak.
11. Children’s Center to Lead Largest-Ever Study on Kidney Disease in Childre
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/16/2017)... ... August 16, 2017 , ... TopConsumerReviews.com recently gave a best-in-class 5 ... , The healthcare industry in the United States has undergone major changes over the ... needing to have a doctor’s order to get a blood test or other lab ...
(Date:8/16/2017)... ... August 16, 2017 , ... Women’s Excellence in ... pain. In addition to oncology services, the new center will specialize in ... heavy bleeding during menstruation), uterine fibroids, and uterine and pelvic adhesions (scar tissue). ...
(Date:8/16/2017)... ... August 16, 2017 , ... Rollon Skin ... anti-aging skincare solutions, recently announced the launch of two new skincare products, Prache ... effective alternative to expensive plastic surgery or in-patient cosmetic dermatological procedures. , “Prache ...
(Date:8/16/2017)... ... ... Chain”: an inspirational story for those shackled by the chains of a broken life. ... writer and a woman of great faith and wisdom. She is a great motivational ... born and raised in Vero Beach, Florida and has dedicated her life and ministry to ...
(Date:8/15/2017)... (PRWEB) , ... August 15, 2017 , ... ... of disease. It’s reaching out to a patient who feels isolated. It’s developing ... amid madness. , WesternU President Daniel R. Wilson, MD, PhD, invited three renowned ...
Breaking Medicine News(10 mins):
(Date:8/7/2017)... 7, 2017 Diplomat Pharmacy, Inc. (NYSE: ... as president, effective Aug. 7, 2017. ... to pursue other interests and will serve as president emeritus ... has served us in multiple leadership roles since he joined ... 2015 and has provided decisive, strategic leadership which continues to ...
(Date:8/3/2017)... -- Opioid addiction and other drugs of abuse, blood poisoning ... outcomes, were problems taken on directly as laboratory professionals, ... them, met this week. This according to Kalorama Information. ... abuse, procalcitonin and acute kidney injury were key focuses ... in San Diego, CA.  Mechanisms ...
(Date:8/1/2017)... CerSci Therapeutics , a non-opioid drug development firm based ... notice from the National Institute on Drug Abuse (NIDA) ... has been awarded a Direct-to-Phase II Small Business Innovation ... an additional $1,000,000 to follow in 2018. These funds ... lead non-opioid drug candidate CT-044 to the Food and ...
Breaking Medicine Technology: